Clinical Trial Update: Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thalidomide with dexamethasone and PET imaging to assess organ involvement in cardiac amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Thalidomide (thalidomide)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Cardiac Amyloidosis | Phase 2 | Status: UNKNOWN